Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
139 WhittakerS.MaraisR.ZhuA
In studies involving inflammatory bowel disease (IBD), the peptide has been shown to mitigate intestinal inflammation, reduce lesion size, and promote the regeneration of the epithelial lining
Because dihexa is investigational, its long-term safety in humans isn't fully established and that uncertainty is itself the reason for medical oversight
PMC (2019) Subcutaneous drug delivery: pharmacologic considerations and techniques American College of Cardiology (2025) REDEFINE 1 and REDEFINE 2 journal scan summary The Lancet (2023) Efficacy and safety of CagriSema in type 2 diabetes: phase 2 trial (Frias et al.) PMC (2024) Efficacy and safety of cagrilintide and CagriSema: systematic review and metaanalysis Pure Lab Peptides Cagrilintide (10 mg) product page (quality and batch documentation) Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
